These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 29146274)

  • 41. Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation.
    Ptaszek LM; Wang PJ; Hunt SA; Valantine H; Perlroth M; Al-Ahmad A
    Heart Rhythm; 2005 Sep; 2(9):931-3. PubMed ID: 16171746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.
    Jiménez-Candil J; Hernández J; Perdiguero P; Martín A; Moríñigo J; Bravo L; Durán O; Sánchez PL
    Am J Cardiol; 2016 Nov; 118(10):1503-1510. PubMed ID: 27634031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    Tsai YN; Cheng WH; Chang YT; Hsiao YW; Chang TY; Hsieh YC; Lin YJ; Lo LW; Chao TF; Kuo MJ; Higa S; Chang SL; Chen SA
    J Cardiol; 2021 Oct; 78(4):275-284. PubMed ID: 34059408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of implantable cardioverter-defibrillators.
    Aronow WS
    Future Cardiol; 2010 Nov; 6(6):859-70. PubMed ID: 21142641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias.
    Katritsis DG; Siontis GC; Camm AJ
    Prog Cardiovasc Dis; 2013; 56(2):133-42. PubMed ID: 24215745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death.
    House CM; Nguyen D; Thomas AJ; Nelson WB; Zhu DW
    J Card Fail; 2016 Feb; 22(2):125-32. PubMed ID: 26522819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent inappropriate implantable cardioverter defibrillator therapy was determined to be dual atrioventricular nodal non-reentrant tachycardia: A case report.
    Ma C; Yin X; Xia Y; Li W; Gao L; Dai S; Yu X
    Medicine (Baltimore); 2021 Apr; 100(14):e25370. PubMed ID: 33832121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling.
    Docherty KF; Campbell RT; Brooksbank KJM; Godeseth RL; Forsyth P; McConnachie A; Roditi G; Stanley B; Welsh P; Jhund PS; Petrie MC; McMurray JJV
    ESC Heart Fail; 2021 Feb; 8(1):129-138. PubMed ID: 33305513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of benazepril on complex ventricular arrhythmias in older patients with congestive heart failure, prior myocardial infarction, and normal left ventricular ejection fraction.
    Aronow WS; Mercando AD; Epstein S
    Am J Cardiol; 1998 Jun; 81(11):1368-70. PubMed ID: 9631980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot.
    Koyak Z; de Groot JR; Bouma BJ; Van Gelder IC; Budts W; Zwinderman AH; Mulder BJ
    Int J Cardiol; 2013 Aug; 167(4):1532-5. PubMed ID: 22608897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators.
    Raad M; Yogasundaram H; Oranefo J; Guandalini G; Markman T; Hyman M; Schaller R; Supple G; Deo R; Nazarian S; Riley M; Lin D; Garcia F; Dixit S; Epstein AE; Callans D; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2024 May; 10(5):846-853. PubMed ID: 38551548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W; Zheng F; Song X; Zhong B; Yan L
    Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Heart failure].
    Yonezawa M; Komuro I
    Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention.
    Pérez-Rodon J; Galve E; Pérez-Bocanegra C; Soriano-Sánchez T; Recio-Iglesias J; Domingo-Baldrich E; Alzola-Guevara M; Ferreira-González I; Marsal JR; Ribera-Solé A; Gutierrez García-Moreno L; Cruz-Carlos LM; Rivas-Gandara N; Roca-Luque I; Francisco-Pascual J; Evangelista-Masip A; Moya-Mitjans À; García-Dorado D
    J Cardiol; 2018 May; 71(5):505-512. PubMed ID: 29183646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.